Caliper Life Sciences of Hopkinton, Mass., and Carestream Health of Rochester, N.Y., have settled two lawsuits.

Bivalirudin (Angiomax, The Medicines Company) may be a viable alternative to heparin plus glycoprotein IIb/IIIa inhibitors (GPIs) in diabetic STEMI patients undergoing primary PCI, according to a substudy of HORIZONS-AMI trial results published in the July issue of JACC: Cardiovascular Interventions. In fact, patients who were administered bivalirudin saw reduced cardiac mortality at both 30 days and one year.

GE Healthcare releases Centricity Advance Mobile, a native Apple iPad application, designed for small primary care physician practices.

Symmetry Medical has signed an agreement to purchase Olsen Medicals assets in an all-cash transaction, upon meeting all pre-closing conditions. The sum was not disclosed.

The University of California, Davis, is partnering with Santa Clara, Calif.-based Agilent Technologies to establish the Davis Millimeter Wave Research Center (DMRC).

The Office of the National Coordinator for Health Information Technology (ONC) issued an advanced notice of proposed rulemaking (ANPRM) recently, soliciting public comment on the metadata standards recommendation by the HIT Standards Committee and HIT Policy Committee.

Despite the significant reduction in un-insurance levels in Massachusetts that occurred with healthcare reform, the demand for care at safety-net facilities continues to rise, stated researchers in an original investigation published Aug. 8 online in the Archives of Internal Medicine.

NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems and developer of healthcare information systems and connectivity tools, has agreed to market and deliver tools and services to medical practices with Dell.